Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

The following is a summary of “Comprehensive analysis of partial confounding clinical symptoms and treatment options of ...

In this case, it was observed that ... with tenapanor treatment. Poster presentations are now publicly available and can be accessed on demand here. In addition to the poster presentation during NKF ...

In a series of interviews with the regional co-chairs of the Social Care Nursing Advisory Councils Madeleine Anderson looks ...